LET 2.5 (Letrozole 2.5 mg)
Pill with imprint LET 2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Dr. Reddy's Laboratories Limited .
Letrozole is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LET 2.5
Letrozole
- Imprint
- LET 2.5
- Strength
- 2.5 mg
- Color
- Yellow
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy's Laboratories Limited
- National Drug Code (NDC)
- 55111-0646 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
hypromelloses,
lactose monohydrate,
magnesium stearate,
polyethylene glycol,
povidone,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "LET 2.5"
More about letrozole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (319)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: aromatase inhibitors
Patient resources
- Other brands
- Femara
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.